(NASDAQ: COYA) Coya Therapeutics's forecast annual earnings growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast earnings growth rate of 11.9%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 36.26%.
Coya Therapeutics's earnings in 2026 is -$21,226,107.On average, 9 Wall Street analysts forecast COYA's earnings for 2026 to be -$35,582,201, with the lowest COYA earnings forecast at -$43,907,155, and the highest COYA earnings forecast at -$30,048,651. On average, 5 Wall Street analysts forecast COYA's earnings for 2027 to be -$27,914,048, with the lowest COYA earnings forecast at -$40,229,069, and the highest COYA earnings forecast at -$16,009,527.
In 2028, COYA is forecast to generate -$5,024,529 in earnings, with the lowest earnings forecast at -$4,827,488 and the highest earnings forecast at -$5,172,309.